Time-lapse fluorescence imaging and quantitative single cell and endosomal analysis of peritoneal macrophages using fluorescent organosilica nanoparticles

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 2, 2013, Pages 274-283

  Nakamura, Michihiro ^a   Miyamoto, Kazunori ^a   Hayashi, Koichiro ^a   Awaad, Aziz ^a   Ochiai, Masahito ^a   Ishimura, Kazunori ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Endosomal uptake; Quantitative single cell analysis; Thiol organosilica particles; Time lapse fluorescence imaging

Indexed keywords

CELLULAR UPTAKE; ENDOSOMAL UPTAKE; FLUORESCENCE IMAGING; FLUORESCENCE MARKERS; FLUORESCENT DYES; HIGH POTENTIAL; ORGANOSILICAS; PERITONEAL MACROPHAGE; SINGLE CELLS; SINGLECELL ANALYSIS; THIOL-ORGANOSILICA PARTICLES; UPTAKE KINETICS;

CYTOLOGY; FUNCTIONAL ANALYSIS; MACROPHAGES; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; SEMICONDUCTOR QUANTUM DOTS; SILICA;

FLUORESCENCE;

FLUORESCENT DYE; FLUORESCENT THIOL ORGANOSILICA NANOPARTICLE; NANOPARTICLE; QUANTUM DOT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOSOME; FLUORESCENCE IMAGING; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; QUANTITATIVE ANALYSIS; SINGLE CELL ANALYSIS; TIME LAPSE IMAGING;

ANIMALS; CELL LINE; ENDOSOMES; FLUORESCENT DYES; MACROPHAGES, PERITONEAL; MICE; NANOPARTICLES; OPTICAL IMAGING; ORGANOSILICON COMPOUNDS; QUANTUM DOTS; SINGLE-CELL ANALYSIS; SULFHYDRYL COMPOUNDS;

EID: 84873730677     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.05.018     Document Type: Article

References (48)

1. Stephens D.J., Allan V.J. Light microscopy techniques for live cell imaging. Science 2003, 300:82-86.
2. Muzzey D., van Oudenaarden A. Quantitative time-lapse fluorescence microscopy in single cells. Annu Rev Cell Dev Biol 2009, 25:301-327.
3. Barretto R.P., Ko T.H., Jung J.C., Wang T.J., Capps G., Waters A.C., et al. Time-lapse imaging of disease progression in deep brain areas using fluorescence microendoscopy. Nat Med 2011, 17:223-228.
4. Shimomura O., Johnson F.H., Saiga Y. Extraction purification and properties of aequorin abioluminescent protein from the luminous hydromedusan Aequorea. J Cell Comp Physiol 1962, 59:223-239.
5. Chalfie M., Tu Y., Euskirchen G., Ward W.W., Prasher D.C. Green fluorescent protein as a marker for gene expression. Science 1994, 263:802-805.
6. Chudakov D.M., Matz M.V., Lukyanov S., Lukyanov K.A. Fluorescent proteins and their applications in imaging living cells and tissues. Physiol Rev 2010, 90:1103-1163.
7. Simpson J.C., Wellenreuther R., Poustka A., Pepperkok R., Wiemann S. Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. EMBO Rep 2000, 1:287-292.
8. Alivisatos A.P. Semiconductor clusters nanocrystals and quantum dots. Science 1996, 271:933-937.
9. Bruchez M., Moronne M., Gin P., Weiss S., Alivisatos A.P. Semiconductor nanocrystals as fluorescent biological labels. Science 1998, 281:2013-2016.
10. Michalet X., Pinaud F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., et al. Quantum qots for live cells in vivo imaging and diagnostics. Science 2005, 37:538-544.
11. Won S., Kim H.D., Kim J.Y., Lee B.C., Chang S., Park C.S. Movements of individual BKCa channels in live cell membrane monitored by site-specific labeling using quantum dots. Biophys J 2010, 99:2853-2862.
12. Tan W., Wang K., He X., Zhao J., Drake T., Wang L., et al. Biotechnology based on silica nanoparticles. Med Res Rev 2004, 24:621-638.
13. Bharali D.J., Klejbor I., Stachowiak E.K., Dutta P., Roy I., Kaur N., et al. Organically modified silica nanoparticles:a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci U S A 2005, 102:11539-11544.
14. Cai W., Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 11:1840-1854.
15. Ohulchanskyy T.Y., Roy I., Goswami L.N., Chen Y., Bergey E.J., Pandey R.K., et al. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Lett 2007, 7:2835-2842.
16. Nakamura M., Shono M., Ishimura K. Synthesis characterization and biological applications of multifluorescent silica nanoparticles. Anal Chem 2007, 79:6507-6514.
17. Nakamura M. Nanostructured Oxides KGaA Weinheim Germany:Wiley-VCH Verlag GmbH & Co; 2009. p. 109-61.
18. Ohulchanskyy T.Y., Roy I., Yong K.T., Pudavar H.E., Prasad P.N. High-resolution light microscopy using luminescent nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2010, 2:162-175.
19. Nakamura M., Ishimura K. Synthesis and characterization of organosilica nanoparticles prepared from 3-mercaptopropyltrimethoxysilane as the single silica source. J Phys Chem C 2007, 111:18892-18898.
20. Nakamura M., Ishimura K. One-pot synthesis and characterization of three kinds of thiol-organosilica nanoparticles. Langmuir 2008, 24:5099-5518.
21. Nakamura M., Ishimura K. Size-controlled one-pot synthesis characterization and biological applications of epoxy-organosilica particles possessing positive zeta potential. Langmuir 2008, 24:12228-12234.
22. Nakamura M., Ozaki S., Abe M., Doi H., Matsumoto T., Ishimura K. Size-controlled synthesis surface functionalization and biological applications of thiol-organosilica particles. Colloid Surface B 2010, 79:19-26.
23. Nakamura M., Ozaki S., Abe M., Doi H., Matsumoto T., Ishimura K. One-pot synthesis and characterization of dual fluorescent thiol-organosilica nanoparticles as non-photoblinking quantum dots and their applications for biological imaging. J Mater Chem 2011, 21:4689-4695.
24. Aderem A., Underhill D.M. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999, 17:593-623.
25. Greaves D.R., Gordon S. The macrophage scavenger receptor at 30 years of age: current knowledge and future challenges. J Lipid Res 2009, 50:S282-S286.
26. Chellat F., Merhi Y., Moreau A., Yahia L. Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005, 26:7260-7275.
27. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration invasion and metastasis. Cell 2006, 124:263-266.
28. Weber C., Zernecke A., Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008, 8:802-815.
29. Qian B.Z., Pollard J. Macrophage diversity enhances tumor progression and metastasis. Cell 2010, 141:39-51.
30. Ishida T., Kashima S., Kiwada H. The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats. J Control Release 2008, 126:162-165.
31. Moghimi S.M., Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics opsonization and protein-binding properties. Prog Lipid Res 2003, 42:463-478.
32. Gullotti E., Yeo Y. Extracellularly activated nanocarriers: a new paradigm of tumor targeted drug delivery. Mol Pharm 2009, 6:1041-1051.
33. Li S.D., Huang L. Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release 2010, 145:178-181.
34. Karakoti A.S., Das S., Thevuthasan S., Seal S. PEGylated inorganic nanoparticles. Angew Chem Int Ed Engl 2011, 9:1980-1994.
35. Nakamura M., Ishimura K. Rapid size evaluation of nanoparticles using flow cytometry. Adv Sci Lett 2010, 3:130-137.
36. Awaad A., Nakamura M., Ishimura K. Imaging of size dependent uptake and identification of novel pathway in mouse Peyer's patches using fluorescent organosilica particles. Nanomedicine: NBM 2012, 8:627-636.
37. Gerion D., Pinaud F., Williams S.C., Parak W.J., Zanchet D., Weiss S., et al. Synthesis and properties of biocompatible water-soluble silica-coated cdse/zns semiconductor quantum dots. J Phys Chem B 2001, 105:8861-8871.
38. Hoshino A., Fujioka K., Oku T., Suga M., Sasaki Y.F., Ohta T., et al. Physicochemical properties and cellular toxicity of nanocrystal quantum dots depend on their surface modification. Nano Lett 2004, 4:2163-2169.
39. Lakowicz J.R. Radiative decay engineering: biophysical and biomedical applications. Anal Biochem 2001, 298:1-24.
40. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
41. Domínguez P.M., Ardavín C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 2010, 234:90-104.
42. Geissmann F., Manz M.G., Jung S., Sieweke M.H., Merad M., Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010, 327:656-661.
43. Ghosn E.E., Cassado A.A., Govoni G.R., Fukuhara T., Yang Y., Monack D.M., et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc Natl Acad Sci U S A 2010, 107:2568-2573.
44. Wolenski J.S., Cheney R.E., Mooseker M.S., Forscher P. In vitro motility of immunoadsorbed brain myosin-V using a Limulus acrosomal process and optical tweezer-based assay. J Cell Sci 1995, 108:1489-1496.
45. Chou L.Y., Ming K., Chan W.C. Strategies for the intracellular delivery of nanoparticles. Chem Soc Rev 2011, 40:233-245.
46. Durazo S.A., Kompella U.B. Functionalized nanosystems for targeted mitochondrial delivery. Mitochondrion 2011, 12:190-201.
47. Boeneman K., Delehanty J.B., Susumu K., Stewart M.H., Medintz I.L. Intracellular bioconjugation of targeted proteins with semiconductor quantum dots. J Am Chem Soc 2010, 132:5975-5977.
48. Nativo P., Prior I.A., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 1639-1644.